Cranial Nerve III Palsy in the Setting of COVID-19 Infection

Autor: John C. Fitzpatrick, John B. Bond, Sean P. Donahue, John M Fitzpatrick, Reid Longmuir, Jordan M Comstock

Publikováno v: Journal of Neuro-Ophthalmology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5be986b6d4368ec81d49d4e920ba6e0

Analgesia for patients undergoing shockwave lithotripsy for urinary stones – a systematic review and meta-analysis

Autor: Laura Beatty, Martin Mariappan, Rami Hasan, Tarik Amer, Gareth E. Jones, John M. Fitzpatrick, Ali Tasleem, Omar Aboumarzouk, Rachael Hutton

Publikováno v: International braz j urol v.43 n.3 2017
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU
International braz j urol, Volume: 43, Issue: 3, Pages: 394-406, Published: JUN 2017
International Brazilian Journal of Urology, Vol 43, Iss 3, Pp 394-406
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology

Background Shock wave lithotripsy (SWL) is the first line treatment modality for a significant proportion of patients with upper urinary tracts stones. Simple analgesics, opioids and non-steroidal anti-inflammatory drugs (NSAIDs) are all suitable age

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a595acf3a9e591ef03f711457452716
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000300394

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation

Autor: Maria Prencipe, Martin Clynes, Amanda O'Neill, Dara Lundon, R.W. Watson, Elaine W. Kay, G. Hurley, Sinead T Aherne, John M. Fitzpatrick, A. Boland, Colm Morrissey, Padraig Doolan, Stephen F. Madden

Publikováno v: BMC Cancer

Background Docetaxel based therapy is one of the first line chemotherapeutic agents for the treatment of metastatic castrate-resistant prostate cancer. However, one of the major obstacles in the treatment of these patients is docetaxel-resistance. De

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4359c3206a6ae75bf2c985cf8caba036
http://europepmc.org/articles/PMC5333466

The Safe and Economical Care of Ta Bladder Cancer

Autor: Roger Kirby, Hugh Mostafid, Richard T. Bryan, John M. Fitzpatrick

Publikováno v: Urology Practice. 1:176-183

Introduction Stage Ta bladder cancer accounts for around half of all new cases of urothelial bladder cancer. It shows heterogeneous behavior with a 5-year recurrence rate of 31% to 78% and a progression rate of 0.8% to 45%. Optimal management is cruc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f4766470d8d823143492ed4934dbadbe
https://doi.org/10.1016/j.urpr.2014.06.006

Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis

Autor: Paul Perrin, Mathieu Boniol, Alberto d’Onofrio, Peter Boyle, David Zaridze, John M. Fitzpatrick, Alice Koechlin, Maria Bota, Arthur L. Burnett

Publikováno v: BJU international. 118(5)

Objective: To review and quantify the association between endogenous and exogenoustestosterone and prostate-specific antigen (PSA) and prostate cancer. Methods: Literature searches were performed according to the Preferred Reporting Items for Systema

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2cbf4097a65fd7c7a69c8f3467e9fd4
https://pubmed.ncbi.nlm.nih.gov/27597096